Our Market Position
Nucleus Network is Australia’s largest and most experienced Phase I Clinical Research Organisation (CRO)
We service global Biotechnology and Pharmaceutical companies from U.S., North America, Europe, and Asia including China, Taiwan and Japan
Years of Operation
More than 15 years
Who we work with
Global Biotechnology and Pharmaceutical companies
Comparative Study Costs: Australia vs. Global markets, including U.S.
Australia is up to 25% more cost effective in a head-to-head comparison to Clinical Trials conducted in the U.S.